Gene Biotherapeutics

Gene Biotherapeutics Inc., formerly Taxus Cardium Pharmaceuticals Group Inc., is engaged in managing a medical technologies portfolio of equity-based and potential royalty-driven investments. The Company's portfolio includes Angionetics, Inc. (Angionetics); Activation Therapeutics, Inc.